The Scientist

» funding, microbiology and immunology

Most Recent

image: Oklahoma De-funds Science Fair

Oklahoma De-funds Science Fair

By | April 12, 2017

Students launch a fundraising campaign to rescue the event, which was a casualty of budget cuts to the state’s education department. 

2 Comments

A mouse study reveals a causal link between changes in intestinal microbiota and increasing inflammation as the rodents age.

0 Comments

image: Report: Boost Funds for Basic Science in Canada

Report: Boost Funds for Basic Science in Canada

By | April 12, 2017

An independent review of Canadian science reveals a need for additional funds to investigator-led, basic research.

0 Comments

Mice exposed to low doses of penicillin in utero or as young pups exhibited long-term behavioral differences not seen in their non-exposed counterparts, according to a study.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

Recolonizing middle-aged animals with bacteria from younger ones kept killifish alive longer than usual, researchers report.

0 Comments

image: Drastic Cuts to Brazil’s Federal Science Budget

Drastic Cuts to Brazil’s Federal Science Budget

By | April 4, 2017

The 44 percent drop in funding is disproportionately large compared to overall reductions in government spending.

0 Comments

image: The Invention Return on NIH Investments

The Invention Return on NIH Investments

By | April 2, 2017

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS